Why CBG is Replacing CBD in Morning Coffee

The cannabinoid market contributes over $28 billion annually to the global wellness economy, and a significant shift is underway. CBD's dominance in functional beverages is being challenged by cannabigerol (CBG), particularly in performance-driven morning rituals. As consumer preferences evolve from relaxation-focused products to those emphasizing mental clarity and productivity, CBG is emerging as the cannabinoid of choice for coffee enhancement. The compound's unique interaction with the endocannabinoid system—combined with mounting clinical evidence of its neuroprotective properties—positions it as a catalyst for the next phase of market growth.

Recent market activity reflects this transformation. Between Q4 2025 and Q1 2026, investment in CBG-focused beverage products increased by 127%, while CBD coffee product launches declined by 34% year-over-year. Major CPG brands are repositioning their product lines accordingly, with several announcing complete reformulations to incorporate CBG as the primary active ingredient. Continue reading to understand the key market dynamics, strategic acquisitions, and future implications of CBG's ascendance in the morning coffee segment through 2026 and beyond.

The Rise of CBG in Functional Coffee: Market Analysis 2026

The cannabinoid-infused coffee market reached $1.8 billion in 2025, now representing 6.3% of the total functional beverage category. A distinct transition is occurring as CBG-focused products captured $340 million in sales—a 218% increase from 2024—significantly outpacing the 12% growth seen in the CBD coffee segment.

The State of the CBG Market in 2026

• Premium Positioning: CBG-infused coffee bags now command prices between $38 and $52, reflecting higher extraction costs compared to the $28–$35 range for standard CBD coffee.

• Clinical Drivers: A landmark January 2026 study in the Journal of Psychopharmacology documented CBG’s interaction with dopamine receptors and $\alpha$2-adrenoceptors, supporting cognitive focus without the "jitters" often associated with high-dose caffeine.

• Bioavailability Tech: Water-soluble CBG formulations utilizing nano-emulsion technology now command 34% higher wholesale prices due to their superior absorption rates compared to standard oil-based extracts.

Primary Drivers and Objectives of CBG Coffee Market Activity

Three fundamental objectives are driving strategic activity in the CBG coffee segment:

Technology and Bioavailability Enhancement: Companies are investing heavily in nano-emulsion technology and liposomal delivery systems to improve CBG absorption rates. Unlike CBD, which has an established bioavailability profile of 13-19% when consumed orally, CBG's oral bioavailability ranges from 6-11%. This technical challenge has created significant opportunities for firms developing proprietary formulation technologies. Water-soluble CBG formulations now command 34% higher wholesale prices than standard oil-based preparations, reflecting the competitive advantage these technologies provide.

Supply Chain Vertical Integration: The limited availability of high-CBG hemp cultivars has driven strategic acquisitions of cultivation operations and breeding programs. CBG content in standard hemp varieties averages 0.5-1%, while specialized cultivars can achieve 15-18% CBG by dry weight. Companies securing access to these genetics through vertical integration reduce input costs by 40-60% compared to purchasing isolated CBG on the spot market, where prices have ranged from $3,500 to $8,200 per kilogram throughout 2025-2026.

Regulatory Compliance and Market Access: As CBG products navigate evolving hemp regulations, companies are acquiring or partnering with firms holding established regulatory infrastructure. The FDA's evolving stance on cannabinoid beverages—combined with state-level variation in hemp-derived compound regulations—has made compliance expertise a valuable asset. Firms with established regulatory pathways can bring products to market 4-6 months faster than competitors developing compliance frameworks from scratch.

Analysis of Key CBG Coffee Market Transactions

Strategic moves between late 2025 and early 2026 illustrate a shift toward vertical integration and clinical substantiation:

• Catalyst Beverages Acquisition of Elevation Extracts (March 2026): In a $47 million vertical integration move, Catalyst secured 340 acres of high-CBG hemp in Oregon. This deal is projected to improve gross margins by 23 percentage points by mid-2027.

• Morning Ritual Coffee Company’s Series C (December 2025): The startup secured $89 million at a $340 million valuation, lead by wellness-focused VCs. The capital is earmarked for expanding manufacturing capacity to meet a projected 340% demand growth.

• Zenith Wellness Group Acquisition of Clarity Coffee Co. (November 2025): This $31 million consolidation gave Zenith a 17% market share, positioning it as the second-largest player in the CBG coffee space.

• Terminated Transaction – Apex Botanicals (February 2026): A proposed $64 million acquisition of Summit Hemp Farms collapsed during due diligence when actual CBG yields averaged only 8.3%, far below the projected 14-16%. This failure led to a temporary 15% sector-wide valuation correction in March 2026.

What These Deals Signal for the Future Wellness Landscape

The transaction activity and market dynamics surrounding CBG coffee products reveal four critical signals about the evolving cannabinoid wellness market:

Market Rationalization and Evidence-Based Positioning: The industry is transitioning from broad wellness claims to targeted, clinically-supported applications. Companies investing in peer-reviewed research and specific cognitive performance claims are achieving premium positioning and customer loyalty. This shift mirrors the broader nutraceutical industry's movement toward evidence-based product development, suggesting the cannabinoid market is maturing beyond early-adopter enthusiasm toward mainstream acceptance.

Shift from Commodity Extraction to Specialized Formulation: Early CBD market dynamics were characterized by commoditized extraction and white-label manufacturing. The CBG market is developing along different lines, with proprietary formulation technology creating sustainable competitive advantages. Nano-emulsion and liposomal delivery systems represent genuine technical barriers to entry, enabling differentiation and margin protection in ways that simple CBD oil extraction never achieved.

Vertical Integration as Competitive Necessity: Unlike CBD, where diverse hemp cultivars provided adequate supply, CBG's limited availability in standard hemp has made cultivation control strategically essential. Companies without vertical integration face both supply constraints and margin pressure, positioning them disadvantageously as the market scales. This dynamic favors larger, better-capitalized firms capable of multi-year investments in breeding programs and cultivation operations.

Consumer Segmentation and Occasion-Based Marketing: The divergence between CBD (positioned for evening relaxation and sleep) and CBG (positioned for morning focus and productivity) represents sophisticated market segmentation. This occasion-based positioning enables brands to capture multiple consumption moments throughout the consumer's day, increasing lifetime customer value and reducing competitive pressure from single-occasion products.

Future Outlook and Stakeholder Implications

The trajectory of CBG in morning coffee markets indicates significant structural changes across the cannabinoid wellness industry. For beverage manufacturers, the transition requires substantial R&D investment in bioavailability enhancement and clinical validation. Companies maintaining commodity-focused extraction operations without formulation expertise face margin compression and market share losses.

Hemp cultivators must evaluate breeding program investments carefully. High-CBG genetics command premium prices, but cultivation expertise and yield consistency separate successful operations from those facing financial distress. The Summit Hemp Farms transaction failure demonstrates the risks of overpromising cultivation capabilities.

Retailers and distributors should anticipate consumer education requirements as CBG products proliferate. Unlike CBD, which benefited from years of consumer familiarity before market saturation, CBG requires explicit positioning around specific use cases and benefits. Retail staff training and point-of-sale education will differentiate successful distribution channels from those where CBG products underperform.

Investors evaluating cannabinoid wellness opportunities should prioritize companies with protected formulation technologies, established clinical research programs, and vertically integrated supply chains. The market's evolution toward evidence-based, performance-oriented products favors firms capable of substantiating claims through peer-reviewed research rather than those relying solely on marketing-driven brand building.

Future implications for stakeholders in CBG coffee markets focus on three critical factors: continued investment in bioavailability technology, vertical integration to ensure supply security, and clinical research to support premium positioning. Subscribe to CBHD to get detailed insights on the cannabinoid wellness industry and future analysis to position your business for success in this rapidly evolving market.